Patents by Inventor Hye Jung Lim

Hye Jung Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral solid dosage form composition having improved disintegration and preparation method therefor
    Patent number: 11980610
    Abstract: Disclosed are an oral solid dosage form composition comprising an active ingredient and a solubilizing carrier wherein a foaming ingredient is used to improve disintegration, dispersion or dissolution, and a preparation method therefor.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: May 14, 2024
    Assignee: SAMYANG HOLDINGS CORPORATION
    Inventors: Sang Yeob Park, Hye Jung Lim, Jae Young Lee, Min Hyo Seo, Sa Won Lee
  • Scanner having flexible probe
    Patent number: 11959886
    Abstract: The present invention relates to a scanner having a flexible probe which is an apparatus capable of being utilized for an inspection on a weld zone of a general ferrite material and a stainless material and allowing an inspection to be performed on a fitting weld zone where it is difficult for a general phased array ultrasonic testing (PAUT) probe to approach.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: April 16, 2024
    Assignees: Foundation for Research and Business, Seoul National University of Science and Technology, Korea Inspection Eng.Co., Ltd
    Inventors: Ik Keun Park, Yu Min Choi, Seong Jin Lim, In Gon Jung, Hye Jin Park
  • Oral tablet formulation of lenalidomide
    Patent number: 11077099
    Abstract: The present disclosure relates to an oral tablet composition comprising lenalidomide and a method for preparing the same. More particularly, the present disclosure relates to a tablet-type composition and a method for preparing the same wherein the composition exhibits physicochemical equivalence with lenalidomide preparations of hard capsules, has the same pharmacological, therapeutic effect in non-clinical studies and bioequivalence studies, and also has improved ease of taking, handling, safety and the like.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: August 3, 2021
    Assignee: SAMYANG HOLDINGS CORPORATION
    Inventors: Sang Yeob Park, Hye Jung Lim, Sa Won Lee, Min Hyo Seo
  • ORAL SOLID DOSAGE FORM COMPOSITION HAVING IMPROVED DISINTEGRATION AND PREPARATION METHOD THEREFOR
    Publication number: 20200261426
    Abstract: Disclosed are an oral solid dosage form composition comprising an active ingredient and a solubilizing carrier wherein a foaming ingredient is used to improve disintegration, dispersion or dissolution, and a preparation method therefor.
    Type: Application
    Filed: October 30, 2018
    Publication date: August 20, 2020
    Applicant: SAMYANG BIOPHARMACEUTICALS CORPORATION
    Inventors: Sang Yeob PARK, Hye Jung LIM, Jae Young LEE, Min Hyo SEO, Sa Won LEE
  • COMPOSITION HAVING IMPROVED WATER SOLUBILITY AND BIOAVAILABILITY
    Publication number: 20200078463
    Abstract: Disclosed are: a composition having improved water solubility and bioavailability, containing sorafenib and a polymethacrylate copolymer; and a preparation method therefor.
    Type: Application
    Filed: April 30, 2018
    Publication date: March 12, 2020
    Applicant: SAMYANG BIOPHARMACEUTICALS CORPORATION
    Inventors: Sang Yeob PARK, Hye Jung LIM, Sa Won LEE, Min Hyo SEO
  • ORAL TABLET FORMULATION OF LENALIDOMIDE
    Publication number: 20200038390
    Abstract: The present disclosure relates to an oral tablet composition comprising lenalidomide and a method for preparing the same. More particularly, the present disclosure relates to a tablet-type composition and a method for preparing the same wherein the composition exhibits physicochemical equivalence with lenalidomide preparations of hard capsules, has the same pharmacological, therapeutic effect in non-clinical studies and bioequivalence studies, and also has improved ease of taking, handling, safety and the like.
    Type: Application
    Filed: September 11, 2017
    Publication date: February 6, 2020
    Applicant: SAMYANG BIOPHARMACEUTICALS CORPORATION
    Inventors: Sang Yeob PARK, Hye Jung LIM, Sa Won LEE, Min Hyo SEO
  • Melt-extruded release controlled pharmaceutical composition and oral dosage form comprising the same
    Patent number: 10143659
    Abstract: Disclosed are a controlled release pharmaceutical composition, comprising a melt-extruded pellet including a water-insoluble ammonium methacrylate copolymer, a polyvinyl acetate, and an active ingredient; and a polymer coating layer including a water-insoluble ammonium methacrylate copolymer formed on the surface of the pellet, and an oral formulation including the pharmaceutical composition.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: December 4, 2018
    Assignee: Samyang Biopharmaceutical Corporation
    Inventors: Sang-Yeob Park, Hye-Jung Lim, Kyung-Hee Kim
  • Highly robust fast-disintegrating tablet and process for manufacturing the same
    Patent number: 9526789
    Abstract: Disclosed are an oral formulation which disintegrates quickly in the oral cavity; a fast-disintegrating tablet having fast disintegrability and high hardness, and a process for manufacturing the same. In addition, slightly wetted granules for manufacturing said fast-disintegrating tablet and a process for manufacturing the same are disclosed.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: December 27, 2016
    Assignee: SAMYANG BIOPHARMACEUTICALS CORPORATION
    Inventors: Sang Yeob Park, Hye Jung Lim
  • Melt-Extruded Release Controlled Pharmaceutical Composition and Oral Dosage Form Comprising the Same
    Publication number: 20160213621
    Abstract: Disclosed are a controlled release pharmaceutical composition, comprising a melt-extruded pellet including a water-insoluble ammonium methacrylate copolymer, a polyvinyl acetate, and an active ingredient; and a polymer coating layer including a water-insoluble ammonium methacrylate copolymer formed on the surface of the pellet, and an oral formulation including the pharmaceutical composition.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 28, 2016
    Inventors: Sang-Yeob Park, Hye-Jung Lim, Kyung-Hee Kim
  • Pharmaceutical Composition Comprising Temozolomide With Improved Stability and Process for Manufacturing the Same
    Publication number: 20160199302
    Abstract: Disclosed are dry granules comprising temozolomide and tartaric acid as a pH stabilizer, a pharmaceutical composition including the dry granules with improved stability and a method of preparing the same.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 14, 2016
    Inventors: Hye-Jung Lim, Sang-yeob Park, Kyung-Hee Kim
  • HIGHLY ROBUST FAST-DISINTEGRATING TABLET AND PROCESS FOR MANUFACTURING THE SAME
    Publication number: 20140364513
    Abstract: Disclosed are an oral formulation which disintegrates quickly in the oral cavity; a fast-disintegrating tablet having fast disintegrability and high hardness, and a process for manufacturing the same. In addition, slightly wetted granules for manufacturing said fast-disintegrating tablet and a process for manufacturing the same are disclosed.
    Type: Application
    Filed: December 28, 2012
    Publication date: December 11, 2014
    Inventors: Sang Yeob Park, Hye Jung Lim
  • Display module
    Patent number: D1017611
    Type: Grant
    Filed: June 26, 2023
    Date of Patent: March 12, 2024
    Assignee: Samsung Display Co., Ltd.
    Inventors: Ho Jung Lee, Kyung Hyun Ko, Yong Woo Koo, Jun Il Kwon, Pablo Kim, Young-Su Kim, Jun Woo Kim, Hoon Kim, Hye Suk An, Hyun Joo Lee, Ki Ho Lim